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We recently published genetic lineage-tracing exper-
iments using the Fezf2 and Cux2 loci. These experi-
ments demonstrated that at both the clonal and
population levels Fezf2+ RGCs are multipotent and
that at the population level Cux2+ RGCs are multipo-
tent. Here, we extend our work on the lineages of
Fezf2+ and Cux2+ RGCs. Clonal analysis of E10.5
neocortical progenitors suggests that most, if not
all, Cux2+ and Fezf2+ RGCs generate diverse projec-
tion neuron subtypes located throughout layers 2–6.
These results support our previous conclusion that
both Fezf2+ andCux2+ RGCs aremultipotent neocor-
tical progenitors. This Matters Arising Response
paper addresses the Gil-Sanz et al. (2015) Matters
Arising paper, published concurrently in Neuron.
INTRODUCTION
Recent work proposes that the neocortex contains distinct clas-
ses of radial glial cells (RGCs), which are intrinsically predis-
posed to generate either deep or upper layer projection neurons.
This model is based upon genetic lineage-tracing experiments,
which concluded that early (embryonic day 10.5 [E10.5]) RGCs
labeled by Cux2-Cre or Cux2-CreERT2-mediated recombination
(Cux2+) are fated to generate corticocortical projection neurons
that reside primarily within upper layers (Franco et al., 2012).
We recently published a study in which we tested this model
using genetic lineage tracing with the Fezf2 and Cux2 loci. This
work demonstrated that: (1) Fezf2-expressing (Fezf2+) RGCs
are multipotent and sequentially generate deep and upper layer
cortical projection neurons followed by macroglia and (2) RGCs
marked by Cux2-CreERT2-mediated recombination are not fate
restricted to generate only corticocortical projection neurons.
Collectively, these results do not support the existence of early
laminar-restricted RGCs within either the Fezf2+ or Cux2+ RGC1100 Neuron 86, 1100–1108, May 20, 2015 ª2015 Elsevier Inc.lineages. Thus, although our results did not exclude their exis-
tence, they demonstrated that neither Fezf2 norCux2 expression
alone is sufficient to identify fate-restricted RGCs.
Here, in response to challenges raised by Gil-Sanz et al.
(2015), we extend our work on the lineages of Fezf2+ and
Cux2+ RGCs. We show that the Cux2-Cre allele does not accu-
rately report the lineage of neocortical RGCs. Moreover, clonal
analysis of E10.5 RGCs using Cux2-CreERT2 and Fezf2-CreERT2
mice indicates that most, if not all, early RGCs labeled by these
alleles generate multiple subtypes of cortical projection neurons
located in layers 2–6. These results reinforce our previous
conclusion that both Fezf2+ and Cux2+ RGCs are multipotent
neocortical progenitors (Guo et al., 2013).RESULTS
The Cux2-Cre Allele Is Not Suitable for Lineage Tracing
of Neocortical RGCs
A significant difference between our previous study (Guo et al.,
2013) and the work of Franco et al. (2012) and Gil-Sanz et al.
(2015) is that the latter two studies relied extensively on the
Cux2-Cre allele to analyze the lineages of RGCs. This allele ex-
presses a constitutively active form of Cre that, when utilized in
combination with Cre-dependent reporters, permanently labels
any cell in which the Cux2 locus has been, or is currently, active.
In addition, any cell derived from a Cux2+ progenitor will be
permanently labeled.
We reported that at E15.5,Cux2-Cre labeled RGCs, basal pro-
genitors, and postmitotic neurons, thus masking the true lineage
of Cux2+ RGCs (Guo et al., 2013). To demonstrate this further, we
bred heterozygous Cux2-Cre mice to homozygous RCE-GFP
and Ai9 reporter mice and examined the brains of double hetero-
zygousmice at postnatal day 28 (P28) (Figures S1A and S1B and
datanot shown).Weobserved strongfluorescence throughout all
cortical layers.Although in somecases labelingof cell bodieswas
evident (FigureS1B), high levels of reporter expression in neurites
complicated the analysis of labeled cell bodies.
To circumvent this, we examined publicly available data from
the Allen Brain Atlas (ABA), which includes extensive analysis of
the same Cux2-Cre and Cux2-CreERT2 alleles that were used in
previous lineage studies (Franco et al., 2012; Guo et al., 2013).
The ABA datasets include in situ hybridization (ISH) experiments
for Cre, Cux2, and tdTomato, which facilitate high-resolution
analysis of cell bodies labeled by the Cre-dependent tdTomato
reporter Ai14 (Madisen et al., 2010). Analysis of P58 Cux2-Cre;
Ai14 mice indicated that Cre expression closely mimicked
Cux2 expression (Figures S1C–S1F). Both Cux2 and Cre
transcripts were highly enriched within upper cortical layers
(L2–L4) with sparse expression in deep layers (L5 and L6). P56
Cux2-CreERT2; Ai14 mice, which received daily administration
of tamoxifen (TM) from P45 to P49, had many tdTomato+ cells
in L2–L4, with sparse cell labeling in deep layers (Figures S1G
and S1H). This expression of tdTomato mRNA indicates that
Cre recombinase driven by the Cux2 locus is active in postmi-
totic neurons.
Compared to Cux2 and Cre expression however, tdTomato
(Figures S1I and S1J) was more broadly expressed throughout
both deep and upper cortical layers in P56 Cux2-Cre; Ai14
mice (compare Figures S1C–S1F with Figures S1I and S1J).
Indeed, while double fluorescence in situ hybridization (dFISH)
for Cux2 and tdTomato demonstrated significant co-expression
in upper layer cells, many tdTomato+ cells in L5 and L6 did not
express Cux2 (Figures S1K–S1O). This suggests that these
deep layer tdTomato+ cells originated from Cux2+ progenitors
or immature neurons but subsequently reduced their Cux2
expression in adult stages.
To further evaluate the distribution of tdTomato+ cells in
P56 Cux2-Cre; Ai14 brains, we analyzed ABA experiments
No. 100144051 (which is the same experiment shown in Fig-
ure S1 of Gil-Sanz et al. [2015]) and No. 113098686. Mice
analyzed in these experiments were generated by breeding
Cux2-Cre heterozygous mice with Ai14 homozygous reporter
mice. We examined multiple cortical areas including the so-
matosensory, somatomotor, primary motor, and visual cortices,
as well as the anterior cingulate and posterior parietal areas.
We found that tdTomato was robustly expressed throughout
both deep and upper cortical layers (Figures S1I, S1J, and
S2). However, in some cortical areas, particularly the anterior
cingulate area, there were fewer tdTomato+ cells in deep layers
(compare Figures S2D2 and S2H2 with S2B–S2D1 and S2F–
S2H1). This indicates that a thorough examination of reporter
expression across multiple cortical areas is required to fully
understand the extent of cell labeling by the Cux2-Cre allele,
as it has a complex temporal and spatial expression pattern
(Figure 1A).
The preceding analysis demonstrates that, in the adult brain,
the Cux2-Cre allele labels cells that are present in both deep
and upper cortical layers, including cells that no longer express
Cux2 at adult stages. Importantly, the recombinase activity of
Cux2-Cre in both progenitor cells and postmitotic neurons
makes it unsuitable for lineage analysis of neocortical RGCs,
because the possibility cannot be excluded that Cux2-Cre-
mediated recombination was initiated in postmitotic neurons
(Figure 1A). A projection neuron labeled by Cux2-Cre may have
originated from a Cux2-Cre+ RGC, a Cux2-Cre+ basal progeni-
tor, or it may have turned on Cre expression postmitotically.
Accordingly, the expression of reporter alleles in Cux2-Cremice is not reflective of the developmental origin of the cells
that express the reporter (Figure 1A).
E10.5 RGCs Marked by Cux2-CreERT2 Generate
Neocortical Projection Neurons in Both Deep and Upper
Layers and Macroglia
Our previous work demonstrated that at the population level,
Cux2+ RGCs are not fate restricted to generate only corticocort-
ical projection neurons (Guo et al., 2013). To extend our analysis,
we performed lineage-tracing experiments using the Cux2-
CreERT2 allele, which expresses an inducible form of Cre that
only induces recombination of a reporter allele for approximately
24–48 hr following tamoxifen administration. This enables label-
ing of Cux2+ RGCs during a short temporal window in order to
track their progeny. In these experiments, we crossed heterozy-
gous Cux2-CreERT2 mice to homozygous RCE-GFP (Sousa
et al., 2009) or Ai9 (Madisen et al., 2010) reporter mice. A single
dose of tamoxifen was injected at E10.5, a time at which postmi-
totic neurons and intermediate progenitors are largely absent in
the developing cortex. Brains from Cux2-CreERT2; Ai9 and
Cux2-CreERT2; RCE-GFP mice were collected at P10 (TM at
E10.5; P10), after cortical projection neurons have migrated to
their final laminar position (Chen et al., 2008; Miyoshi and Fishell,
2012) (Figure 1B). We injected tamoxifen at 100 mg per kg of
body weight, a concentration that reliably generated sparse
labeling in the cortices of these mice. Whole-mount examination
of the brains revealed sparse columns of reporter+ cells (Fig-
ure S3A), suggesting that these cells may be clonally related.
Although we refer to the spatially isolated columns of labeled
cells as clones, we cannot exclude the possibility that some of
the clones may consist of progeny from more than one RGC.
This caveat, however, does not change the interpretation of
our analysis with regard to the lack of lineage restriction within
the Cux2+ RGC lineage.
To examine the progeny of early Cux2+ RGCs, we analyzed
serial brain sections and reconstructed 43 clones from 6 mice
(Figures 1C–1D and S3C and Table S1). We focused our analysis
on spatially isolated columns of cells that predominantly con-
sisted of projection neurons and macroglia. We excluded indi-
vidual cells that were sparsely distributed throughout the cortex,
as they were likely labeled interneurons. The number of cells in
each clone varied from 13 to 227 with an average of 83 cells
per clone (Figure 1E and Table S1). Cells in the clones spanned
an average of 350 mm along the rostral-caudal axis (Table S1).
The number of cells per clone and physical dispersion of the cells
in the clones is similar to that reported for E10.5 RGC clones in a
recent study that utilized Mosaic Analysis with Double Markers
(MADM) to label RGC progeny at clonal density (Gao et al.,
2014). Of the 43 reconstructed clones, 30 (70%) contained
both neurons and glia, while 13 (30%) consisted of only neurons
(Table S1). Strikingly, 100% of the E10.5 Cux2-CreERT2-labeled
clones that we examined contained projection neurons located
in cortical layers 2–6 (Figures 1C–1D and S3C). The 43 reconsti-
tuted clones contained a total of 3,562 lineage-traced cells of
which 90%exhibited a characteristic neuronal morphology while
10%exhibited glial morphologies (Figure 1F and Table S1). Anal-
ysis of the 3,188 lineage-traced neurons demonstrated that their
distribution in deep and upper layers was roughly equivalentNeuron 86, 1100–1108, May 20, 2015 ª2015 Elsevier Inc. 1101
Figure 1. Individual E10.5 Cux2+ RGCs Generate Cortical Projection Neurons and Macroglia Located throughout Cortical Layers 2–6
(A) The constitutive activity of the Cre recombinase makes the Cux2-Cre allele unsuitable for lineage analysis of neocortical RGCs.
(B) Experimental methodology for lineage analysis of Cux2+ RGCs using the Cux2-CreERT2 allele.
(C and D) Examples of TM at E10.5, P10 Cux2+ RGC clones. For each clone, a lower-magnification image is shown first to illustrate the position of the clone in the
cerebral cortex, followed by higher-magnification images of serial sections that span the entire clone. (C1), (C2), and (C3) show neurons, an astrocyte, and an
oligodendrocyte found within the clone shown in (C).
(E) Scatter plot of the number of cells for each of the 43 clones analyzed.
(legend continued on next page)
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(55% upper layer neurons versus 45% deep layer neurons)
(Figure 1G and Table S1). This distribution of lineage-traced
neurons is similar to that observed in lineage-tracing experi-
ments of E10.5 RGCs using the Nestin-CreERT2 (Franco et al.,
2012), Emx1-CreERT2 (Gao et. al. 2014), and Fezf2-CreERT2
alleles (Figure 3 and Table S1). These results provide strong
evidence that most, if not all, individual Cux2+ RGCs aremultipo-
tent and generate projection neurons in cortical layers 2–6 and
macroglia.
Molecular Analysis of the Cux2 Lineage
We next analyzed the molecular expression profiles of
tdTomato+ and GFP+ cells in TM at E10.5; P10, Cux2-CreERT2;
Ai9 and Cux2-CreERT2; RCE-GFP mice. To restrict our analysis
to the progeny of neocortical Cux2+ RGCs, we focused only on
projection neurons and glia that were part of putative RGC
clones and excluded the sparsely distributed individual cells
that were likely interneurons. We analyzed 6,258 neocortical
cells from 4 animals. Among 2,583 lineage-traced deep layer
neurons, 33.9% ± 9.5% expressed the subcerebral neuron
marker CTIP2 (McKenna et al., 2011; Molyneaux et al., 2005)
(Figures 2A–2T and 2AA). When lineage-traced, deep layer neu-
rons were analyzed by double labeling with antibodies for CTIP2
and TBR1, a marker for corticothalamic neurons (Bedogni et al.,
2010; Han et al., 2011; Hevner et al., 2001;McKenna et al., 2011),
23.7% ± 8.7% expressed TBR1 alone, and 18.8% ± 3.8% ex-
pressed both TBR1 and CTIP2 (Figures 2A–2E and 2AA). Similar
results were observed with another corticothalamic neuron
marker DARPP32 (McKenna et al., 2011), which was co-ex-
pressed in TdTomato+ or GFP+ deep layer neurons (Figures
2F–2J). We also investigatedmolecular expression profiles using
a combination of antibodies against CTIP2 and SATB2, another
projection neuron marker (Alcamo et al., 2008; Britanova et al.,
2008). Within L5 and L6, 35.8% ± 5.7% of lineage-traced neu-
rons expressed SATB2 and 13.2% ± 2.5% expressed both
SATB2 and CTIP2 (Figures 2K–2O and 2AA). Thus, within deep
cortical layers, projection neurons generated from E10.5 Cux2+
RGCs express four molecular markers previously associated
with different projection neuron subtypes.
We examined 3,064 tdTomato+ or GFP+ neurons within the
upper layers (L2–L4) of TM at E10.5; P10 Cux2-CreERT2; Ai9
or Cux2-CreERT2; RCE-GFP mice. As expected, significant
numbers of these cells expressed CUX1 (64.6% ± 8.2%) (Cube-
los et al., 2010) or SATB2 (68.3% ± 10.4%) (Alcamo et al., 2008;
Britanova et al., 2008), two markers previously associated with
upper layer callosal projection neurons (Figures 2K–2T and
2AA). In addition, some lineage-traced cells exhibited character-
istic astrocyte or oligodendrocyte morphology and expressed
GFAP or OLIG2, respectively (Figures 2U–2Z). Thus, results
from molecular expression analyses further strengthen the evi-
dence that early Cux2+ RGCs are not lineage restricted to
generate only upper layer or corticocortical projection neurons.
Rather, these data support the conclusion that Cux2+ RGCs(F) Quantification of the percentages of neurons and glia generated from E10.5 C
(G) Quantification of the percentages of all lineage-traced cells, neurons, and glia t
Ctx, cerebral cortex; DL, deep cortical layers (layers 5 and 6); Hip, hippocampus; U
and 250 mm in Inserts.generate a diversity of projection neuron subtypes and macro-
glia that reside within both deep and upper cortical layers.
Cux2+ RGCs and Fezf2+ RGCs Generate Similar Progeny
Wepreviously demonstrated that early Fezf2+ RGCs aremultipo-
tent and sequentially generate projection neurons andmacroglia
(Guo et al., 2013). To extend our clonal analysis of Fezf2+ RGCs,
we bred Fezf2-CreERT2 animals to RCE-GFP or Ai9 reporter
mice, administered a single low dose of tamoxifen at E10.5,
and analyzed brains at P10 (Figure 3A). We reconstituted 46
clones from 3 animals (Figures 3B–3C and S3D and Table S1).
The number of cells in each clone varied from 13 to 242 with
an average of 67 cells per clone, and the clones spanned an
average of 300 mm along the rostral-caudal axis (Figure 3D and
Table S1). Twenty-eight percent of the clones contained only
neurons, and 72% contained both neurons and glia. Similar to
E10.5 Cux2+ RGCs, 100% of Fezf2+ RGC clones contained neu-
rons located throughout cortical layers 2–6 (Figures 3B–3C and
S3D). We quantified the distribution of the 3,100 lineage-traced
cells in the 46 E10.5 Fezf2 clones and found that, comparable
to results from clonal analysis using the Cux2-CreERT2 allele,
Fezf2+ RGCs generated projection neurons (88%) and glia
(12%) (Figure 3E and Table S1). Lineage-traced neurons were
located in both deep (44%) and upper (56%) layers (Figures
3B–3C and 3F and Table S1).
We examined 2,328 deep layer lineage-traced neurons from 3
brains that consisted of both fully and partially reconstructed
clones and found that 26.8%± 5.0%of these neurons expressed
CTIP2 (Figure 3G). When lineage-traced neurons were analyzed
using antibodies for CTIP2 and TBR1, 23.5% ± 3.0% of deep
layer neurons expressed TBR1 alone, and 8.8% ± 2.9% ex-
pressed both CTIP2 and TBR1 (Figure 3G). We also analyzed
reporter+ neurons in L5 and L6 using a combination of CTIP2
and SATB2 antibodies and found that 30.8% ± 1.4% expressed
SATB2 alone, and 7.6% ± 3.3% expressed both SATB2 and
CTIP2 (Figure 3G). Within upper cortical layers, lineage-traced
neurons expressed CUX1 (47.1% ± 5.9%) or SATB2 (59.7% ±
4.7%) (Figure 3G). Notably, the percentage of lineage-traced
neurons that expressed each of these markers is similar to that
observed with TM at E10.5; P10 Cux2-CreERT2 mice (Figures
2AA, 3G, and 3H). Collectively, our clonal and molecular ana-
lyses suggest that both Fezf2+ RGCs and Cux2+ RGCs are
multipotent and generate multiple subtypes of projection neu-
rons and macroglia.
RetrogradeTracingConfirms thatCux2+RGCsGenerate
Subcerebral Projection Neurons
Thus far, we have provided evidence that Cux2+ RGCs generate
neurons located in deep cortical layers that also express molec-
ular markers for subcerebral projection neurons. To confirm that
these neurons extend axons to subcerebral targets, we com-
bined Cre-dependent lineage analysis with retrograde tracing
(Figure 4A). We bred heterozygous Cux2-CreERT2 mice toux2+ RGCs based upon the analysis of 43 fully reconstructed clones.
hat were located in deep or upper layers. Abbreviations: CR, Cajal-Retzius cells;
L, upper cortical layers (layers 2–4). Scale bars represent 500 mm in (C) and (D)
Neuron 86, 1100–1108, May 20, 2015 ª2015 Elsevier Inc. 1103
Figure 2. Cux2+ RGCs Generate Diverse, Molecularly Defined Subtypes of Cortical Projection Neurons and Macroglia
All images are of brain sections from P10Cux2-CreERT2; Ai9 (A–T) or P10Cux2-CreERT2; RCE-GFP (U–Z) mice that received a single tamoxifen injection at E10.5
(TM at E10.5; P10). Lineage-traced neurons expressed TBR1 (A–E), DARPP32 (F–J), SATB2 (K–O), CUX1 (P–T), or CTIP2 (A–T). (B)–(E), (G)–(J), (L)–(O), and (Q)–(T)
show the higher-magnification images of the boxed areas in (A), (F), (K), and (P), respectively. The arrowheads in (B)–(E), (G)–(J), (L)–(O), and (Q)–(T) point to cells
(legend continued on next page)
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homozygous RCE-GFP reporter mice, and administered a single
dose of tamoxifen at E10.5 (100 mg/kg), to mark the progeny of
Cux2+ RGCs. We then injected cholera toxin beta (Ctß) into the
pyramidal tract at P8 (Figures 4A and S3B).
Ctß injection into the pyramidal tract labeled a subset of
subcerebral projection neurons located in layer 5 (Figure 4C).
Notably, we observed GFP; Ctß double-positive cells in Cux2-
CreERT2; RCE-GFP mice, indicating that these subcerebral
neurons were generated from Cux2+ RGCs (Figures 4D–4F).
We quantified the percentage of GFP+ cells derived from
Cux2+ RGCs that projected subcerebral axons inCux2-CreERT2;
RCE-GFP brains. We found that 11.5% ± 1.1% of GFP+ cells in
layer 5 and 4.4% ± 0.4% of GFP+ cells in layers 5 and 6 were
retrogradely traced (Figure 4B).
We performed a similar analysis using the Fezf2-CreERT2 allele
(Figures 4A and 4G–4J), which was previously shown to label
RGCs that generate neurons that project axons to the corpus
callosum, thalamus, and spinal cord (Guo et al., 2013). Strikingly,
Fezf2-CreERT2; RCE-GFP and Cux2-CreERT2; RCE-GFP brains
contained similar percentages of GFP; Ctß double-positive cells
(10.3%± 0.9%L5 and 3.3%± 0.6%L5 and L6 for Fezf2-CreERT2
allele) (Figure 4B). These results confirm that both Cux2+ and
Fezf2+ RGCs produce subcerebral projection neurons and
demonstrate that early Cux2+ RGCs are not lineage restricted
to generate only corticocortical projection neurons.
DISCUSSION
Our previous study demonstrated that at both the clonal and
population levels Fezf2+ RGCs are multipotent and that at the
population level Cux2+ RGCs are multipotent (Guo et al.,
2013). This result suggested that either all Cux2+ RGCs are
multipotent or, alternatively, Cux2+ RGCs might represent a het-
erogeneous population with different lineage potentials. Herein,
our lineage analysis of individual Cux2+ RGCs provides evidence
that most, if not all, Cux2+ RGCs are multipotent and generate
diverse projection neuron subtypes located in cortical layers
2–6. Further, we found that the laminar distribution and molecu-
lar expression profile of neurons generated from early Cux2+
RGCs was similar to that of neurons generated from early
Fezf2+ RGCs (Figure 3), Nestin-CreERT2+ RGCs (Franco et al.,
2012), and Emx1-CreERT2+ RGCs (Gao et al., 2014).
Using the Cux2-Cre and Cux2-CreERT2 alleles, Franco et al.
(2012) reported that Cux2+ RGCs generated only neurons and
not glia. They also reported that among the progeny generated
by E10.5 Cux2-CreERT2-labeled RGCs, 90% of labeled cells
were located in upper cortical layers while 10% were in deep
layers. These data are significantly different from our previous
and current results. By using two Cre reporter lines, RCE-GFP
andAi9, analyzing 6,258 lineage-traced cells, and reconstructing
43 RGC clones, we observed that at P10 roughly 10% of cells
generated from E10.5 Cux2+ RGCs were astrocytes or oligoden-
drocytes. Moreover, we found that every E10.5 RGC clone wethat are shown in higher magnification to the right. (U–Z) E10.5 lineage-traced C
drocytes that expressed OLIG2 (X–Z). (AA) Percentages of lineage-traced deep la
represent SD. Abbreviations: Ctx, cerebral cortex; Hip, hippocampus. Scale bars
in (W) and (Z).examined contained neurons located in both deep and upper
cortical layers and that there was not a strong bias of the labeled
cells to occupy upper cortical layers.
Both the current study and Gil-Sanz et al. (2015) demonstrate
that Cux2+ RGCs generate a greater percentage of SATB2+ than
CTIP2+ neurons. However, Gil-Sanz et al. (2015) interpret the
prevalence of SATB2+ neurons labeled by the Cux2-Cre and
Cux2-CreERT2 alleles as evidence that Cux2+ RGCs are lineage
restricted. SATB2 is expressed in a greater number of neocor-
tical cells compared to CTIP2 (Figure S4; see also Figure 3E of
Gil-Sanz et al. [2015]). Thus, it is not surprising that a multipotent
RGC, which generates diverse subtypes of projection neurons,
can produce a higher percentage of SATB2+ than CTIP2+ prog-
eny. This highlights the need to define projection neuron subtype
identity using multiple parameters, including additional molecu-
lar markers and axonal projections. Toward this, we found that
a similar percentage of neurons with subcerebral projections
were born from Cux2+ RGCs and Fezf2+ RGCs labeled at
E10.5 (Figure 4).
Gil-Sanz et al. (2015) attribute the difference in results between
experiments performed in the Mu¨ller laboratory (Franco et al.,
2012;Gil-Sanzet al., 2015) andourwork (Guoet al., 2013andcur-
rent study) to breeding strategy and genetic background. The au-
thors propose that the low recombinationefficiencyweobserve in
Cux2-CreERT2mice at E10.5, using a TMdosage of 100mg/kg of
body weight, is an artifact of genetic background. Furthermore,
they suggest that our lineage analysis results with the Cux2-
CreERT2 allele are highly influenced by genetic background. Gil-
Sanz et al. (2015) report that the Cux2-CreERT2 allele previously
induced more widespread recombination at a TM dosage of
50 mg/kg when compared to the current study. We disagree;
our interpretation of Figure S2 from Franco et al. (2012) is that
sparse recombination was prevalent at this dosage, similar to re-
sults from our laboratory. Moreover, in Gil-Sanz et al. (2015), the
authors injected 4-hydroxytamoxifen (4-OHT) at a dosage of
50mg/kg of bodyweight (or 1mg/20 g) to achieve sparse labeling
of E10.5Cux2+ RGCs. However, 4-OHT has amuch greater affin-
ity (503–1003) than TM for binding estrogen receptors (Malet
et al., 1988) and is significantly more potent at inducing recombi-
nation (Hans et al., 2009). Thus, the recombination efficiency of
the Cux2-CreERT2 allele in studies from the Mu¨ller laboratory
does not appear to be significantly higher than that observed in
our laboratory (compare Figures 1 and 2 in the current study
with Figures 3 and S3D–S3I of Gil-Sanz et al. [2015]).
One explanation for the divergent conclusions reached by our
work and that of Franco et al. (2012) and Gil-Sanz et al. (2015) is
that the latter two studies relied heavily onCux2-Cremice, which
are not suitable for lineage analysis of neocortical RGCs. Here
we present evidence that explains why the lineage analysis of
neocortical RGCs is confounded by the complex temporal and
spatial expression pattern of the Cux2-Cre allele. The recombi-
nase activity of Cre driven from the Cux2 locus is constitutively
active and thus recombination can occur in RGCs, basalux2+ RGCs generated astrocytes that expressed GFAP (U–W) and oligoden-
yer and upper layer neurons that expressed the indicated markers. Error bars
represent 500 mm in (A), (F), (K), and (P), 100 mm in (E), (J), (O), and (T), and 25 mm
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Figure 3. Similar to Early Cux2+ RGCs, E10.5 Fezf2+ RGCs Generate Diverse Subtypes of Cortical Projection Neurons and Glia
(A) Experimental methodology.
(B–C) Two examples of clones generated from E10.5 Fezf2+ RGCs. For each clone, a lower-magnification image is shown first to illustrate the position of the clone
in the cerebral cortex, followed by higher-magnification images of serial sections that span the full clone.
(D) Scatter plot of the number of cells for each of the 46 clones analyzed.
(E) Quantification of the percentages of lineage-traced cells that were neurons or glia.
(legend continued on next page)
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Figure 4. Retrograde Labeling of the Cux2+
and Fezf2+ Lineages
(A) Experimental setup.
(B) Percentages of GFP+ cells in layer 5 or in layers
5 and 6 that are also Ctß positive. Error bars
represent SD (n = 2 brains for Cux2 and 6 brains for
Fezf2).
(C–F) Example of brain sections from Cux2-
CreERT2; RCE-GFP mice that received TM at
E10.5 and were injected with Ctß at P8. Note the
dense band of Ctß labeling in layer 5. (D)–(F) show
an enlarged view of boxed region in (C). Arrow-
heads indicate GFP+ cells originating from a Cux2+
RGC that extend subcerebral projections.
(G–J) Exampleof brain section fromFezf2-CreERT2;
RCE-GFP mouse that received TM at E10.5 and
was injected with Ctß at P8. (H–J) Enlarged view of
boxed regions shown in (G). Arrowheads indicate
GFP; Ctß double-positive cells. Abbreviations: Ctx,
cerebral cortex; Hip, hippocampus; LV, lateral
ventricle. Scale bars represent 500mm in (C) and (G)
and 100 mm in (F) and (J).progenitor cells, or postmitotic neurons. Accordingly, a reporter+
neuron in the cortical plate may not have originated from aCux2+
RGC. Within the neocortex, Cux2 is preferentially expressed in
upper cortical layers. Therefore, a higher percentage of re-
porter-expressing cells within upper versus deep cortical layers
in a small subset of cortical areas (e.g., the anterior cingulate
area) in Cux2-Cre mice is not unexpected based upon the
expression pattern of Cux2 and does not indicate that Cux2+
RGCs preferentially generate upper layer neurons.
Recently, Gao et al. (2014) performed lineage analyses of
individual RGCs using MADM. Through low-density labeling of
RGCs with the Emx1-CreERT2 and Nestin-CreERT2 alleles, they
reported that 100% of clones generated from RGCs labeled at
E10.5 contained neurons that occupied cortical layers 2–6.
Notably, despite the differences in recombination efficiency be-
tween the MADM strategy and our current study, the average
numbers of cells per clone and rostral-caudal dispersion of cells
in the clones are similar between the two studies. Moreover, by
analyzing subtype-specific markers, Gao et al. (2014) found that
individual clones contained cells expressing markers for multiple
subclasses of neocortical projection neurons. Combined with
the current study, this work provides important evidence for
the prevalence of multipotent RGCs within the early neocortical
progenitor pool.
Collectively, our results demonstrate that early Cux2+ and
Fezf2+ RGCs are multipotent neocortical progenitors. However,(F) Quantification of the percentages of lineage-traced cells, neurons, and glia that were located in deep an
(G) Percentages of lineage-traced deep layer and upper layer neurons that expressed the indicated markers
(H) Percentages of deep layer neurons generated from E10.5 Cux2+ or E10.5 Fezf2+ RGCs that expressed co
Error bars represent SD. Abbreviations: Ctx, cerebral cortex; Hip, hippocampus; LV, lateral ventricle. Scale ba
in Inserts.
Neuron 86, 1100–11these findings do not exclude the exis-
tence of fate-restricted RGCs during early
cortical development. Rather, they indi-cate that neither Fezf2 nor Cux2 expression alone is sufficient
to identify these cells and that appropriate molecular or genetic
markers await future investigation.EXPERIMENTAL PROCEDURES
All experiments were carried out in accordance with the protocols approved
by the IACUC at University of California at Santa Cruz and institutional and
federal guidelines. The day of vaginal plug detection was designated as
E0.5. The day of birth was designated as P0. Immunohistochemistry was per-
formed as previously described (Eckler et al., 2011). Extended experimental
details are included in Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.neuron.2015.04.020.AUTHOR CONTRIBUTIONS
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